Brief

SARS-CoV-2/InFluA/InFluB Rapid Antigen Test (Immunochromatography Assay) is intended for the qualitative detection of the SARS-CoV-2/InFluA/InFluB nucleocapsid protein in human nasopharyngeal or oropharyngeal swabs. Test results will be available for reading in 15-20 minutes. Positive results indicate the presence of viral antigens. This kit is for in vitro diagnostic use.

Features

• Accurate LOD 80TCID₅₀ /ml, Specificity 100%
• Convenient No instrument needed, easy to operate
• Fast Result available in only 15-20 min

Instruction

Result interpretation

Parameters

Qualification

CE

Kit components

No.	Product Name	Spec.
S3121E-25	SARS-CoV-2/InFluA/InFluB Rapid Antigen Test (Immunochromatography Assay)	25 Test

The kit components:

• SARS-CoV-2/InFluA/InFluB Antigen Test Cassette (individually in a foil pouch with desiccant)
• Sample Extraction Buffer
• Swab

Brief

The SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay) for self-testing is authorized for home use with self-collected nasal swab samples to directly detect antigen of SARS-CoV-2 virus. With the help of this kit, people without professional training can also easily acquire their COVID-19 test result within 15-20 minutes.

Features

• Accurate Sensitivity 94.55%, Specificity 100%
• Convenient No instrument needed, easy to operate
• Fast Result available in only 15-20 min
• Flexible Get tested anytime when you are free

Instruction

Result interpretation

Parameters

Qualification

CE

Kit components

No.	Product Name	Spec.
S3120E-1-H, S3120E-5-H S3120E-10-H, S3120E-25-H	SARS-CoV-2 Rapid Antigen Test (Immunochromatography Assay)	1 Test, 5 Tests 10 Tests, 25 Tests

The kit components:

•  SARS-CoV-2-Antigen Test Cassette (with desiccant)
• SARS-CoV2 Sample Extraction Buffer
• Specimen Collection Swab
• Plastic Waste Bag

Brief

The SARS-CoV-2 Neutralizing Antibodies Test (Colloidal Gold) is intended for the qualitative detection of the SARS-CoV-2 Neutralizing Antibodies in human serum, plasma and whole blood sampled from individuals after vaccination or after the infection with SARS-CoV-2.

Features

Instruction

Result interpretation

Parameters

Qualification

CE

Order information

No.	Product Name	Spec.
S3131E-25	SARS-CoV-2 Neutralizing Antibodies Test (Colloidal Gold)	25T/kit

The kit components:

• SARS-CoV-2 Neutralizing Antibodies Test Cassette
• Sample Diluent Buffer
• Blood Lancet for Single Use
• Dropper
• Alcohol Pad

Brief

The SARS-CoV-2 Rapid Antigen Test (Colloidal Gold Method) is intended for the qualitative detection of the SARS-CoV-2 nucleocapsid protein in human nasopharyngeal or nasal swab sampled from individuals suspected of COVID-19.

Parameters

Testing Time	10-15 minutes
Sensitivity	98.4%
Specificity	98.1%
Qualification	CE

Kit components

No.	Product Name	Spec.
S3109E-25	SARS-CoV-2 Rapid Antigen Test (Colloidal Gold Method)	25 tests

Brief

The SARS-CoV-2 Mutation Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is used to identify whether the virus contains mutation sites N501Y and HV 69-70del in nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluids, saliva and sputum from patients who have been diagnosed with SARS-CoV-2 infection.

Performance

• ARMS-PCR: Accurate detection of N501Y, HV 69-70delmutation sites
• Ultra fast: Optimize testing procedures, amplification time only 60min
• High sensitivity: Detection sensitivity reaches 200 copies/mL
• Internal control: Rnase P, Monitor the whole process (Sampling, Extraction and Amplification )

Parameters

Product features	Parameters
Specimen Type	Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum
Extraction Platform	One-tube fast release technology / Advanced magnetic beads technology
Target Genes	N501Y, HV 69-70del, N gene
Internal Control	Rnase P gene
PCR Instrument	SLAN-96P, ABI7500, QuantStudio 5
Sensitivity	200copies/mL
Spec.	24T/48T
Qualification	CE

Brief

Detection Kit for 5 Mutations of SARS-CoV-2, detects 5 SARS-CoV-2 variants, including E484K, K417N, P681H, N501Y and HV 69-70del, which covers Most Worrying Mutations.

Performance

• More comprehensive: Accurate detection of 5 mutation sites
• Ultra fast: Optimize testing procedures, amplification time only 60min
• High sensitivity: Detection sensitivity reaches 200 copies/mL
• Internal control: Rnase P, Monitor the whole process

Parameters

Product features	Parameters
Specimen Type	Oropharyngeal swab, sputum, alveolar lavage fluid, nasopharyngeal swab and saliva
Extraction Platform	Advanced magnetic beads technology
Target Genes	E484K, K417N, P681H, N501Y, HV 69-70del, N gene
Internal Control	Rnase P
PCR Instrument	SLAN-96P, ABI7500, QuantStudio 5
Sensitivity	200copies/mL
Spec.	24T/48T
Qualification	CE

Brief

COVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2.   Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.   The SARS-CoV-2 Multiplex Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is used for qualitative detection of the ORF1ab,N and E genes of SARS-CoV-2 in nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum from patients with SARS-CoV-2 infection, suspected cases with SARS-CoV-2 infection and other patients requiring diagnosis or differential diagnosis of SARS-CoV-2 infection.

Performance

• Performance upgrade: ORF 1ab, N, E genes, three targets
• High sensitivity: 200 copies/ml (one-tube fast release technology), 50 copies/ml (advanced magnetic beads method)
• Time saving: the amplification time was 60min, and the extraction time was the shortest 30min

Parameters

Product features	Parameters
Specimen Type	Nasopharyngeal swab, oropharyngeal swab, alveolar lavage fluid, saliva and sputum
Extraction Platform	One-tube fast release technology Advanced magnetic beads technology
Target Genes	ORF 1ab, N, E gene
Internal Control	Pseudovirus containing internal control gene fragments
PCR Instrument	SLAN-96P, ABI7500, QuantStudio 5, iPonatic S-Q31A&B
Sensitivity	200 copies/mL (Sample Release Reagent ); 50 copies/mL (Nucleic Acid Extraction-Purification Kit )
Spec.	24T, 48T, 96T, 12-P
Qualification	CE